Macular edema in the era of spectral-domain optical coherence tomography
Allan Hunter,1 Eric K Chin,1 David G Telander,21Department of Ophthalmology, University of California, Davis, 2Department of Ophthalmology, Retinal Consultants, Sacramento, CA, USAAbstract: The development of spectral-domain optical coherence tomography (OCT) allows for the highest commercially avai...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7e12bd2aac9d46e39f61e0f84dfca9e3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Allan Hunter,1 Eric K Chin,1 David G Telander,21Department of Ophthalmology, University of California, Davis, 2Department of Ophthalmology, Retinal Consultants, Sacramento, CA, USAAbstract: The development of spectral-domain optical coherence tomography (OCT) allows for the highest commercially available resolution of in vivo retinal anatomic details to date. The ability to see the macula with ever increasing detail is dramatically improving our understanding of the pathogenesis of retinal disease. However, the only prospective study that partially evaluated spectral-domain OCT versus time-domain OCT failed to show any clinical benefit of increased OCT resolution. Clinical outcomes, eg, best-corrected visual acuity, central macular thickness and number of injections, with “newer” OCT technologies remain an unproven advantage.Keywords: retina, macular edema, optical coherence tomography, fluorescein angiography, indocyanine green angiography |
|---|